Niosome is a non-ionic surfactant-based Vesicle (biology and chemistry). Niosomes are formed mostly by non-ionic surfactant and cholesterol incorporation as an excipient. A liposome is a spherical vesicle having at least one lipid bilayer. The liposome can be used as a vehicle for administration of nutrients and pharmaceutical drugs.
2. Niosomes are a novel drug delivery system, in which the
medication is encapsulated in a vesicle composed of a bilayer
of non- ionic surface active agents.
Figure: Structure of niosome
3. According to the nature of lamellarity
Multilamellar vesicles (MLV) 1- 5 µm in size.
Large Unilamellar vesicles (LUV) 0.1 - 1µm in size.
Small Unilamellar vesicles (SUV) 25- 500 nm in
size.
According to the size
Small Niosomes (100nm – 200 nm)
Large Niosomes (800nm – 900nm)
Big Niosomes (2µm - 4µm)
4. Ether injection
Hand shaking
Sonication
The reverse phase evaporation technique
Bubble method
Transmembrane pH gradient drug uptake
process
Emulsion method
5. Shape & Morphology
Transmission Electron Microscopy (TEM)
Particle size
Entrapment Efficiency
Cell Cytotoxicity Study
Stability study
In vitro release study
6. For controlled release of drugs
To improve the stability and physical properties of
the drugs
For targeting and retention of drug in blood
circulation
Cosmetics
Studying immune response
7. A liposome is a spherical vesicle having at least one
lipid bilayer. The liposome can be used as a vehicle
for administration of nutrients and pharmaceutical
drugs.Liposomes can be prepared by disrupting
biological membranes (such as by sonication).
Figure: Structure of liposome
8. Liposome Types
Size Number of Lamellae
Small Unilamellar Vesicles
(SUV)
20 nm - 100 nm Single
Large Unilamellar Vesicles
(LUV)
100 nm - 400 nm Single
Giant Unilamellar Vesicles
(GUV)
1 µm and Larger Single
Large Multilamellar Vesicles
(MLV)
200 nm - ~3 µm Multiple
Multivesicular Vesicles (MVV) 200 nm - ~3 µm Multiple
10. Particle size
Surface charge
Percent drug encapsulated
Phase behaviour
Drug release rate
11. Enhanced solubility of amphiphilic and lipophilic drugs
Inactive objective to the cells of the immune system
Maintained free system of systemically or locally administered
liposomes.
Site-avoidance mechanism
Improved transfer of hydrophilic, electric molecules such as
antibiotics, chelators, plasmids and genes, into cells.
12. SI NO. Niosomes Liposomes
1. Vesicles made up of
surfactants with or without
incorporation of cholesterol
Vesicles made up of
concentric bilayer of
phospholipis
2. Size ranges from 10- 100
nm
Size ranges from 10-
3000nm
3. Inexpensive Comparatively expensive
4. Special storage conditions
are not required
Special storage conditions
are required
5. Non- ionic surfactants are
stable
Phospholipids used are
unstable
6. Less toxic Comparatively more toxic